ultrasensitive detection talk 13-5-13 fv
TRANSCRIPT
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
1/28
Acute phase proteins, homeostasis regulators ApoH a tool to reach unmet ultrasensitive diagnostics needs
to detect pern icious m icroorganisms
1
FranciscoVeas,PhD
LaboratoiredImmuno-PhysiopathologieMolculaireCompare
UMR-MinistryofDefense3-IRD-AMU
&CSOofApoH-Technologies
FacultyofPharmacy-UM1
MontpellierFrance
[email protected](mobilephone+33681416506)
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
2/28
2
Acutephaseproteins&homeosta1cfunc1ons
The acute phase response consists in a change in the concentra0on ofseveralplasmaproteins,mostlysynthesizedintheliver,including:
GroupIincreaseupto5%(ceruloplasminandcomplementfactor-3(C3))
Group II from 2 to 5 0mes (haptoglobin, fibrinogen, -globulins withan0protease-ac0vityandlipopolysaccharidebindingprotein)
Group III from 5 to more than 1 0mes (CRP and SAA) (Dowton &
Colten,1988).
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
3/28
3
ApoHcaptureaproprietarytechnology
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
4/28
4
ApoHcaptureaproprietarytechnology
molecularmassof5kDaHighstabilityofsolidsupport-coatedApoHformsplasma0cconcentra0oncloseto2mg/LApoHcomprises5domains:4SCR(shortconsensusrepeats)fromCCP(complementcontrolprotein)moduletypeandafiVhlysinerich
domain(withalargepatchof14posi0velychargedresidues)
unusualcomposi0onwith6.2%cysteineand8.3%proline.Hydrophobicinterac0onwithanionicphospholipids(PS,Cardiolipin,someofwhicharepresentinHI,HC..)Protein-Proteininterac0on(Staphylococcusaureus)Highmicroorganismcaptureaffinityandefficiencyofthroughnovelphysico-chemicalcondi1ons
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
5/28
5
ApoHcapturetechnology
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
6/28
FunctionalApoH-coatednano-magneticbeads
Work8low
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
7/28
7
capture Magnetic
separation
Puri8ication
washes
concentrationonApoHbeads
Virus/baxteriaPCR
serum+
beadsApoH
elution Beads
elimination
pathogenss
magnetApoHbeads
pathogen
Bacteria
CultureInhibitor
ApoHtechnology
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
8/28
8
ApoHaforclinicaldiagnos1cofviralinfec1ons
Currentblood(orotherscomplextargetmatricesassputum,urineetc)pathogendetec0on&iden0fica0onmethods(including
moleculartechniques)s0llgeneratenumerousfalsenega1ve
resultswhenviralloadislowand/orthepresenceofinhibitorsof
detec0on.
ApoHtechnology,isthetoolpermi^ngtobeusefulin:
personalizedmedicine:byshortendelayinthediagnosis&earlystagemanagementofviralinfec0ons(isola0onofpa0ents)
inPublicHealthissues:regardingmanagementofepidemics,aswellassafertransplanta0onsandtransfusions
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
9/28
9
ApoHaforclinicaldiagnos1cofviralinfec1ons
An1-HBsAgenrichedsucrose
frac1on&layereddirectly
onEMgrids
SupernatantApoH-unbound
ofcentrifuged460KG(DNA
NEG)=HbsAg
ApoH-enrichedsucrose
frac1on
An1-HBsAgenriched&layered
onan1-ApoHApoHcomplex
HEPATOLOGY2001;33:207-217.)
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
10/28
10
ApoHaforclinicaldiagnos1cofviralinfec1ons
Highly positive Plasma Suspected Plasma
0
500000
000000
500000
2000000
2500000
23
4
5 6 78
Viralload(copies/ml)
withoutApoH-beads
withApoH-beads
Serum dilution
Low positive Plasma
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
11/28
11
ApoHaforclinicaldiagnos1cofviralinfec1ons
82samplesincludingpa0ents:- withlowviralload- suspectedofHCinfec0onbutnega0velydiagnosed.
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
12/28
12
ApoHaforclinicaldiagnos1cofsuspectedDengueinfec1ons
DENVcopies/mL
Differentgenera1onsofApoH-coatedbeadstodetectDENV
withPCRinserafromCambodianindividuals
withnega1vediagnos1c
: Sample S522168 was previously (IPC) weakly positive & ** : Sample S5606185 previously (IPC) positive blue bars were obtained without ApoHa but with a new qPCR for dengue)>70% of false negatives were solved !!!!!!
* **
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
13/28
A
B
C
IgM IgG
Ctrl
IgM +
IgG -
IgG +/-IgM +
Sera Neg CTRL
PCR Neg CTRL
Early diagnosis of Hantavrius could play a critical role in prognostic of patients
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
14/28
Lab strain
No virus
isolated strain #1
isolated strain #2
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
15/28
102
10-2
dilution series
103
104
105
106
101
100
10-3 10-4 10-5 10-610-1
copies/r
xn
spiked with cell cultured virusesstored for 24 hr @ room tempdiluted in 4 mL MEMwithout ApoHwith ApoH-beads
Results
Pa1entsamplecopies/rxn
withoutApoH withApoH
.7E+05 .8E+06
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
16/28
Apo-H captured H3N2 using an
anti-H3N2 MAb
H3N2 infection detection using an
anti-H3N2 MAb
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
17/28
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
18/28
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
19/28
19
ApoHaforclinicaldiagnos1cofbacterialinfec1ons
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
20/28
20
ApoHaforclinicaldiagnos1cofbacterialinfec1ons
Currentbacterialdetec0on&iden0fica0onmethodsare:(i)tooslowand/or(ii)notsensi1veenough
topromptlydrivean0-biotherapyforlife-threateninginfec0ons
(sep0cemia..)or,fornosocomialscreening.
Bloodculturebaseddiagnosistakes3daysormore(>0days) ,hasalackofsensi1vity(falsenega0veduetopresenceofan0bio0cs)
Molecularmethodss1lldofaceasensi1vityissuedueto:
thechallengetoconcentrateafewpathogensoutofseveralmlofblood, thepresenceofinhibitors
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
21/28
Bacillus sp. Ochrobactrum anthropi
Bacteroides fragilis Prevotella orisBacteroides ureolyticus Porphyromonas endodontalis
Acinetobacter baumannii Propionibacterium acnes
Candida albicans Proteus mirabilis
Capnocytophaga canimorsus Providencia stuarti
Chlamydia trachomatis Pseudomonas aeruginosa
Citrobacter freundi Pseudomonas sp.
Coagulase-negative Staphylococcus Salmonella arizonae
Corinebacterium sp. Salmonella enteritidesEnterobacter aerogenes Salmonella typhirium
Enterococcus faecalis Serratia marcescens
Enterobacter cloacae Staphylococcus aureus
Escherichia coli Staphylococcus epidermidis
Fusobacterium nucleatum Staphylococcus hominis
Klebsiella pneumoniae Streptococcus bovis
Listeria monocytogenes Streptococcus mitis
Micrococcus sp Streptococcus pyogenesMycobacter *Tropheryma whipplei (difficult to cultivate)
Mycobacterium chelonae * *spores & ***fungi
21
ApoHaforclinicaldiagnos1cofbacterialinfec1ons
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
22/28
ApoH:exhibitahighaffinityforinfec0ousbacteriabutalowaffinityforcommensalbacteriafromthegut&fromcollec0ons(ATCC).
0
10
20
30
40
0 10 20 30 40
Cp
Time(min)
Swab Urine
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
23/28
27 hemocultivation false positive(CO2 positive but negative sub cultivation)
147 CO2-producing ApoH-tested hemocultures
64positives ApoH -
Subcultivation &PCR
64 positives ApoH+Subcultivation & PCR
0 positive ApoH-
Subcultivation &PCR9 positives ApoH
+
Subcultivation & PCR
0 positive ApoH-Subcultivation &PCR
11 positives ApoH+
Subcultivation & PCR
64 hemocultivation positives
Clinicaldata
ApoHtest&diagnostic
56 hemocultivation negatives
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
24/28
1: K. Pneumoniae sans billes ApoH
2: K. Pneumoniae avec billesApoH
3: S. aureus sans billes ApoH4: S. aureus avec billesApoH
5: Coagulase-ngative Staphylococcus sans billes ApoH
6: Coagulase-ngative Staphylococcus avec billesApoH
7: P. acnes sans billes ApoH
8: P. acnes avec billesApoH9: Contrle positif l (ADN bactrien)
10: H2O
1 2 3 4 5 6 7 8 9 101 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
25/28
25
ApoHaforclinicaldiagnos1cofbacterialinfec1ons
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
26/28
26
Generalconclusion()
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
27/28
27
Generalconclusion(2)
-
7/30/2019 Ultrasensitive Detection TALK 13-5-13 FV
28/28
28
Specialthanks&contacts:
EuropeanUSDEPproject UniversityMontpellier,France TheFrenchResearchIns1tuteforDevelopmentOSEO,theFrenchinnova1onagencyTheRegionLanguedocRoussillonFranceLaboratoiredImmuno-PhysiopathologieMolculaireCompareTheApoH-Technologiestech-team&colls:GregorDubois,EstelleLucarz,SylviaTigre
&IliasStefas(CEO)
Biotechnologies-Dveloppement-Conseil (France,USA,Israel&Japan),Chris1anPolicardCEO(formerCEOofPasteurIns0tuteBusinessDev&formerCEOofSanofi-PasteurDiagnos0cs )